Structural Studies on Supramolecular Adducts of Cyclodextrins with the Complex [Ru([9]aneS3)(bpy)Cl]Cl by Marques, Joana et al.
Accepted Manuscript
Structural Studies on Supramolecular Adducts of Cyclodextrins with the Com
plex [Ru
([9]aneS
3
)(bpy)Cl]Cl
Joana Marques, Lucia Anjo, Maria P.M. Marques, Teresa M. Santos, Filipe A.
Almeida Paz, Susana S. Braga
PII: S0022-328X(08)00384-7
DOI: 10.1016/j.jorganchem.2008.06.023
Reference: JOM 15536
To appear in: Journal of Organometallic Chemistry
Received Date: 23 April 2008
Revised Date: 16 June 2008
Accepted Date: 18 June 2008
Please cite this article as: J. Marques, L. Anjo, M.P.M. Marques, T.M. Santos, F.A. Almeida Paz, S.S. Braga,
Structural Studies on Supramolecular Adducts of Cyclodextrins with the Complex [Ru([9]aneS
3
)(bpy)Cl]Cl, Journal
of Organometallic Chemistry (2008), doi: 10.1016/j.jorganchem.2008.06.023
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting proof before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
  
 
ACCEPTED MANUSCRIPT 
 
 1 
Manuscript for J. Organomet. Chem.       23/06/2008 
 
Structural Studies on Supramolecular Adducts of Cyclodextrins with the Complex 
[Ru([9]aneS3)(bpy)Cl]Cl 
 
 
Joana Marques,[a] Lucia Anjo,[a] Maria P. M. Marques,[b] Teresa M. Santos,[a] 
Filipe A. Almeida Paz,[a] and Susana S. Braga *[a] 
 
[a] Department of Chemistry, CICECO, University of Aveiro, 3810-193 Aveiro, Portugal 
Fax: (internat.) + 351-234-370084 
E-mail: sbraga@ua.pt 
[b] Science and Technology Faculty, Molecular Physical Chemistry Research Group, Department of 
Chemistry, University of Coimbra, Apt. 3126, 3001-401 Coimbra, Portugal  
 
 
Keywords: Cyclodextrins / Inclusion compounds / Ruthenium complexes / Powder X-ray Diffraction /  
 
________________________________________________________________________________ 
The complex [Ru([9]aneS3)(bpy)Cl]Cl (bpy = 2,2´-bipyridine) was immobilised in plain -cyclodextrin 
(-CD) and permethylated -CD (TRIMEB) to yield two adducts with a 1:1 host:guest stoichiometry. The 
adducts were studied by powder X-ray diffraction (XRD), thermogravimetric analysis (TGA), 13C{1H} 
CP/MAS NMR and vibrational spectroscopy (FT-IR and Raman). Results support the formation of stable 
supramolecular adducts with a proposed geometry in which the coordinated bypiridine fragment of the 
guest is partially included in the host cavities, and the bulky [9]aneS3 fragment protrudes out to the 
interstitial spaces. A packing mode is proposed for [Ru([9]aneS3)(bpy)Cl]Cl·TRIMEB, obtained by 
Monte Carlo optimisation of the XRD data. TRIMEB molecules are stacked in tilted channels, with the 
voluminous part of the guest molecules in the inter-channel space. The behaviour of 
[Ru([9]aneS3])(bpy)Cl]Cl upon CD encapsulation and the chloride ligand hydrolysis process in solution 
for all compounds were studied in detail by Raman spectroscopy. 
________________________________________________________________________________ 
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1. Introduction 
 
Cyclodextrins (CDs) are water soluble cyclic oligosaccharides capable of forming inclusion compounds 
with a wide range of organic molecules, inorganic ions and metallo-organic species [1-3]. Suitable guests 
include transition-metal complexes and organometallic compounds bearing hydrophobic ligands such as 
cyclopentadienyl (Cp = 5-C5H5) and 6-arene groups [4-6], capable of docking into the host cavity by 
non-covalent bonding (either van der Waals or charge-transfer interactions). We have explored the 
protecting and bio-delivery properties of these hosts to enhance the activity of antitumour metal 
compounds such as ferrocene derivatives [7] and metallocene dihalides, in particular Cp2MCl2 (Cp = 
cyclopentadienyl, M = Nb, Mo) [8-10]. In particular, cytotoxic assays carried out for pure and included 
molybdenocene dichloride showed a higher activity upon encapsulation, in particular when using 
permethylated -cyclodextrin (TRIMEB) [9]. We have also used cyclodextrin encapsulation to modulate 
the activity of carbonyl organometallics such as CpFe(CO)2X (X = Cl, CN) [11-13], Cp'Mo(3-
C3H5)(CO)2 [14], CpMo(LL)(CO)2 (L = 2 × CH3CN or LL = 2,2’-bis-imidazole) [15] and 
CpMo(CO)3CH2CONH2 [16]. The latter compound was revealed to be a useful catalyst with a wide range 
of applications modulated by the host: whilst the -CD inclusion compound is suitable for heterogeneous 
solid–liquid systems, the TRIMEB inclusion compound is instead more suited to homogeneous or liquid–
liquid biphasic systems. 
Our most recent work is focused on the application of ruthenium complexes as cytotoxic agents. For this 
purpose, some of us have developed a series of Ru(II) complexes with the face-capping ligand 
trithyacyclononane ([9]aneS3) and planar aromatic amines suitable for DNA intercalation [17]. The 
crystal structures of these compounds were found to be largely stabilised by hydrogen bonding 
interactions and the coordinated planar aromatic amines exhibit -stacking arrangements which mimic the 
structure of polypyridyl complexes intercalated with DNA. The intercalative properties of some of these 
compounds have also been demonstrated by UV/Vis titration studies, in particular for 
[Ru([9]aneS3)dppzCl]Cl (dppz = dipyrido[3,2a:2’,3’c]phenazine) [18]. Following the strategy of 
molecular encapsulation that allowed us to improve the cytotoxic properties of molybdenocene dichloride 
[4b], here we wish to report the first supramolecular adducts of the trithyacyclononane-Ru(II) guest 
[Ru([9]aneS3)(bpy)Cl]Cl (bpy = 2,2´-bipyridine) with the cyclodextrin hosts -CD and 2,3,6-tri-O-
methyl--CD (TRIMEB). 
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2. Experimental 
 
2.1.General remarks 
-CD was kindly donated by laboratoires La Roquette (France), and heptakis-2,3,6-tri-O-methyl--CD 
was obtained from Cyclolab. All air-sensitive operations were carried out using standard Schlenk 
techniques under nitrogen. Solvents were dried by standard procedures, distilled under nitrogen or argon, 
and kept over 4 Å molecular sieves. 
Microanalyses for CHN were performed at the University of Cambridge (Department of Chemistry) on an 
Exeter Analytical CE 440 Elemental Analyser.  Samples were combusted under an oxygen atmosphere at 
975°C for 1 minute, and helium used as purge gas. The ruthenium content was determined by ICP-OES 
analyses at the Central Laboratory for Analysis, University of Aveiro (by L. Soares). 
TGA studies were carried out using a Shimadzu TGA-50 system at a heating rate of 5 ºC min–1 under air. 
Powder X-ray diffraction data were collected at ambient temperature on an X’Pert MPD Philips 
diffractometer (Cu Kα X-radiation,  = 1.54060 Å), equipped with an X’Celerator detector, a curved 
graphite-monochromated radiation and a flat-plate sample holder, in a Bragg-Brentano para-focusing 
optics configuration (40 kV, 50 mA).  Intensity data were collected in continuous scanning mode in the 
ca. 4  2º  70 angular range. 
FT-IR spectra were recorded on a Unican Mattson Mod 7000 FTIR spectrophotometer. 
13C{1H} CP/MAS NMR spectra were recorded at 125.72 MHz on a (11.7 T) Bruker Avance 500 
spectrometer, with an optimised /2 pulse for 1H of 4.5 s, 2 ms contact time, a spinning rate of 7 kHz 
and 12 s recycle delays. Chemical shifts are quoted in parts per million from tetramethylsilane. 
 
2.2. Preparation of [Ru([9]aneS3)(bpy)Cl]Cl (1) 
This compound was prepared as described in the literature [19].  
FT-IR (KBr, cm–1): nu(tilde) = 3529 s, 3434 vs, 3355 vs, 3061 m, 2975 m, 2931 m, 2075 m, 1642 s,  1622 
sh, 1599 s, 1470 s, 1443 s, 1411 s, 1314 m, 1274 m, 1240 m, 1221 w, 1160 m, 1107 m, 1016 w, 961 w, 
911 m, 823 m, 766 vs, 761 vs, 747 sh, 730 s, 706 m, 676 w, 647 w, 567 m, 540 m, 473 w, 425 w. 13C{1H} 
CP/MAS NMR: δ = 156.8, 155.2 (bpy Ca, see carbon labelling scheme below), 152.4 (bpy Ce), 135.0, 
140.0 (bpy Cc), 127.8, 126.8 (bpy Cd), 122.8 (bpy, Cb), 39.8, 38.7, 36.5, 31.5, 29.7, 28.8 ppm (all 
[9]aneS3). 
N N
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2.3. Preparation of [Ru([9]aneS3)(bpy)Cl]Cl·-CD (2) 
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A solution of β-CD (47.3 mg, 0.036 mmol) in water (10 cm3) at 25 ºC was treated dropwise with a 
solution of [Ru([9]aneS3)(bpy)Cl]Cl (1) (18.4 mg, 0.036 mmol) in acetonitrile (10 cm3), and the resultant 
orange solution was stirred for 20 min at 25 ºC and then immediately frozen using liquid nitrogen. After 
solvent removal by freeze-drying, a pale orange voluminous powder was obtained. Anal. Calcd for 
(C42H70O35)·(C16N2H20S3RuCl2)·10H2O (1858.4) C, 38.20; N, 1.54; H, 6.08%. Found: C, 37.92; N 1.35; 
H, 7.00%. TGA up to 78 °C revealed a sample weight loss of 8.6% (calcd: for loss of 9H2O, 8.8%). 
FT-IR (KBr, cm–1): nu(tilde) = 3387 vs, 2927 m, 1636 m, 1604 sh, 1465 sh, 1445 m, 1412 m, 1384 m, 
1334 m, 1300 m, 1242 m, 1202 m, 1156 s, 1098 sh, 1078 s, 1029 vs, 1002 s, 946 m, 937 m, 911 w, 888 
w, 859 m, 824 w, 762 m, 722 w, 706 m, 647 vw, 609 m, 581 m, 531 m, 480 vw, 447 vw, 358 w, 302 m. 
13C{1H} CP/MAS NMR: δ = 155.1, 152.6, 144.2, 140.0, 128.3, 123.8 (guest, bipyridine), 103.0 (β-CD, 
C1 – see numbering scheme below), 82.4 (β-CD, C4), 73.0 (β-CD, C2,3,5), 60.8 ppm (β-CD, C6), 36.7, 
31.6 (guest, [9]aneS3). 
 
 
2.4. Preparation of [Ru([9]aneS3)(bpy)Cl]Cl·TRIMEB (3) 
A solution of TRIMEB (143.0 mg, 0.10 mmol) in ethanol (5 cm3) was treated stepwise with solid 
[Ru([9]aneS3)(bpy)Cl]Cl (1) (50.8 mg, 0.10 mmol)  and stirred for 1 h. The solution was then evaporated 
to dryness, giving an orange solid. Anal. Calcd for 3 (C63H112O35)·(C16N2H20S3RuCl2)·6H2O (2010.7): C, 
47.19; N, 1.39; H, 7.22; Ru, 5.03. Found: C, 47.13; N, 1.14; H, 6.68; Ru, 5.22%. 
FTIR (KBr, cm–1): nu(tilde) = 3442 s, 3066 m, 2984 s, 2939 s, 2833 m, 1733 m, 1623 m, 1600 m, 1558 w, 
1541 w, 1464 m, 1446 m, 1403 sh, 1384 s, 1322 m, 1306 m, 1270 m, 1232 sh, 1195 s, 1165 vs, 1142 vs, 
1108 vs, 1089 vs, 1068 vs, 1038 vs, 973 s, 954 m, 909 m, 857 m, 827 m, 806 w, 772 s, 731 m, 705 m, 668 
m, 554 m, 4217 m, 399 w, 350 w, 340 w. 13C{1H} CP/MAS NMR: δ = 155.2, 151.4, 140.6, 138.2, 129.0 
(guest, bipyridine), 99.8 (TRIMEB, C1), 83.1 (TRIMEB, C2,3,4), 71.6 (TRIMEB, C5,6), 58.8 ppm 
(TRIMEB, O–CH3), 39.2, 36.7, 30.6 (guest, [9]aneS3). 
 
2.5. Hydrolytic studies in solution 
Hydrolysis of the Ru–Cl bond in the complex ion [Ru([9]aneS3])(bpy)Cl]+ was monitored in 
solution (at concentrations between 5 and 10 mmol.dm-3) by Raman spectroscopy, both aqueous and in 
physiological serum ([Cl-] = 0.9% (w/v)= 154 mmol.dm-3).  
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Raman spectra were obtained for the solutions, at room temperature, in a triple monochromator 
Jobin-Yvon T64000 Raman system (focal distance 0.640 m, aperture f/7.5) with holographic gratings of 
1800 grooves.mm-1. The premonochromator stage was used in the subtractive mode. The detection 
system was a liquid nitrogen cooled non-intensified 1024×256 pixel (1") Charge Coupled Device (CCD). 
The entrance slit was set to 200 µm, and the slit between the premonochromator and the spectrograph was 
opened to 12 mm. 
The excitation radiation was provided (ca. 120 mW at the sample position) by the 514.5 nm line of 
an Ar+ laser (Coherent, model Innova 300). A 90º geometry between the incident radiation and the 
collecting system was employed. Samples were sealed in Kimax glass capillary tubes of 0.8 mm inner 
diameter. Under the above mentioned conditions, the error in wavenumbers was estimated to be within 1 
cm-1. 
 
  
 
ACCEPTED MANUSCRIPT 
 
 6 
3. Results and Discussion 
 
Preparation of the inclusion compounds with the guest salt [Ru([9]aneS3)(bpy)Cl]Cl (1) was 
carried out using a minimal amount of water as the solvent so to avoid the decomposition of the metallic 
complex due to chloride hydrolysis. In the case of TRIMEB, co-dissolution in ethanol was the process of 
choice. This “water-free” inclusion process developed by us for methylated cyclodextrins was revealed to 
be quite suitable for guests that are unstable in water [20,21]. For the dissolution of  -CD water is 
required, thus a short time of reaction (20 minutes) was used to prevent chloride hydrolysis. Elemental 
analysis of compounds [Ru([9]aneS3)(bpy)Cl]Cl·-CD (2) and [Ru([9]aneS3)(bpy)Cl]Cl·TRIMEB (3) 
confirmed the expected 1:1 host:guest molar ratio for the final products. 
Preliminary structural investigations using X-ray diffraction data allowed an immediate 
confirmation of the presence of true inclusion compounds of cyclodextrins because the collected patterns 
for 2 and 3 are markedly distinct from those obtained by the superimposition of the diffractograms of the 
pure host and guest components [2]. In the case of adduct 2, although the overall pattern reveals a low 
crystallinity, one may find a few broad reflections centred at 4.4, 8.9, 10.6, 12.5 and 17.6 2º that do not 
match those of neither of the components (-CD or 1); the same can be observed for adduct 3, as shown 
in Figure 1. 
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Figure 1 – Powder XRD patterns of (a) [Ru([9]aneS3)(bpy)Cl]Cl (1), (b) -CD hydrate, (c) the 
adduct [Ru([9]aneS3)(bpy)Cl]Cl·-CD (2), (d) TRIMEB and (e) the adduct 
[Ru([9]aneS3)(bpy)Cl]Cl·TRIMEB (3).  
 
The features of the powder patterns for 2 and 3 are also markedly typical [8,12], namely the 
presence of low-resolved reflection lines at low angle, a significant background, and low-intensity or even 
indiscernible reflections at high angles. Noteworthy, the low crystallinity of the samples seems to be 
directly related with the geometrical features of the included species. Indeed, the relatively large size of 
the cationic [Ru([9]aneS3)(bpy)Cl] + complex possibly induces a considerable structural disorder in the 
solid-state packing of the host and guest chemical species. This feature, allied with the inherent thermal 
disorder associated with the water molecules of crystallisation and the structural flexibility of the 
cyclodextrin rings, most likely leads to the isolation of materials with low long-range order. 
Despite the very low overall crystallinity of the sample, the experimental powder X-ray diffraction 
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pattern of [Ru([9]aneS3)(bpy)Cl]Cl·-CD (2) could be indexed with DICVOL04 [22] (fixed absolute error 
on each line of 0.03º 2; no impurity lines were allowed) using the first 18 more intense and better 
resolved reflections (located using the derivative-based peak search algorithm provided with 
Fullprof.2k) [23,24]. Systematic absences for an initially-calculated monoclinic unit cell were inspected 
using CHECKCELL [25], which indicated space group P21 as the most suitable to define the overall 
symmetry of the material. A Le Bail whole-powder-diffraction-pattern profile decomposition [26] using 
fixed (and manually selected) background points produced a reasonably good fitting (RBragg = 0.48% and 

2
 = 1.90 – see Figure S1 in the Electronic Supporting Information) with the unit cell parameters of this 
inclusion compound converging to: a = 20.72(1) Å, b = 10.296(6) Å, c = 15.096(7) Å and 
 = 109.05(5) Å (M18 = 10.4  [27], and F18 = 15.2 [28]). A search in the literature revealed a single known 
and closely related material recently reported by the research groups of Kurokawa & Ishida in which 
[CuCl2(H2O)2] complexes co-crystallise with -CD [29]. It is interesting to emphasise that in this 
previously-reported material the copper(II) complexes are not included inside the hydrophobic cavities of 
the cyclodextrin, sitting instead at the bottom of the host.  Comparing the total volumes for the unit cells 
[ca. 3033 and 3044 Å3 for [CuCl2(H2O)2]·-CD and 2, respectively] it is thus feasible to assume that in 2 
the guest complex are most likely included inside the cavity of the host. Moreover, there is a small 
increase in the length of the c-axis, which is also coherent with a small increase in the spatial separation 
between -CDs most likely due to the presence of bulky ruthenium(II) complexes.  The poor quality of 
the diffractogram for compound 2 did not allow any further structural studies. 
Compound [Ru([9]aneS3)(bpy)Cl]Cl·TRIMEB (3) is significantly more crystalline, as clearly 
depicted in Figure 2.  Indexing of the powder X-ray diffraction pattern and analysis of the systematic 
absences were performed by adopting a similar strategy to that described for the previous compound and 
using in tandem the software packages DICVOL04, Fullprof.2k and CHECKCELL.  It is important to 
stress that a plausible initial monoclinic indexing could only be computed, and having reasonable figures 
of merit (M14 = 12.1, and F14 = 35.8), when the presence of one or more impurity lines was allowed.  
Indeed, solutions which account for all the initial (and better resolved) reflections selected from the 
powder pattern, further assuming a peak position error of ±0.03º, could only be derived using the 
TREOR90 algorithm [30] with all belonging to the triclinic crystal system.  As revealed by a search in the 
Cambridge Structural Database (CSD, Version 5.29 – November 2007) [31,32] there is not a single 
known report of a triclinic unit cell containing TRIMEB molecules.  Moreover, further structural studies 
by assuming these triclinic unit cell solutions in FOX [33,34] did not lead to better structural models and, 
consequently, these triclinic solutions were discarded.  The monoclinic solution was refined in space 
group P21 by employing a Le Bail whole-powder-diffraction-pattern profile decomposition (fixed 
background points were manually selected from the powder pattern): a = 19.295(4) Å, b = 16.664(3) Å, 
c = 15.426(3) Å and  = 104.224(9) Å (RBragg = 1.28% and 2 = 9.75 – see Figure S2 in the Electronic 
Supporting Information). 
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A plausible structural model derived from powder X-ray data for 
[Ru([9]aneS3)(bpy)Cl]Cl·TRIMEB (3) was calculated using the software package FOX [33,34] and by 
adopting the general principles previously described by us for related materials [8,12].  This systematic 
strategy probes all possible structural orientations in direct space of the selected chemical entities (which 
are treated as rigid bodies), thus leading to the selection of the most chemically-feasible structural model 
for the compound in study.  The geometrical parameters for the TRIMEB cyclodextrin were extracted 
from the first adduct with an organometallic guest [CpFe(CO)2Cl], fully characterised by single-crystal 
X-ray diffraction and recently reported by us [11].  For the guest molecular entity, 
[Ru([9]aneS3)(bpy)Cl]+, a search in the CSD reveals only two known crystallographic reports in which 
this cation co-crystallises with Cl-/H2O (CSD refcode RIFMOI) [19] or trifluorosulfonate anions (CSD 
refcode YAVNIT) [35].  Because the geometrical features for [Ru([9]aneS3)(bpy)Cl]+ do not change 
considerably for different counter-ions, and also because we have employed the chloride salt for the 
preparation of compound 3, the molecular geometry of RIFMOI was selected for further studies.  The 
host and guest molecules were transformed into Fenske-Hall Z-matrices calculated using BABEL 
(hydrogen atoms have been removed in order or simplify the calculations) [36].  For the cationic 
[Ru([9]aneS3)(bpy)Cl]+ complex (guest) the central ruthenium atom was selected as the pivot atom which 
greatly facilitates the mobility of this molecular unit during the optimisation process. 
Monte Carlo optimisations (using the optimised parallel tempering algorithm) were launched in 
FOX [33,34] with the three individual mathematical objects (the TRIMEB host, the guest ruthenium(II) 
cationic complex and a charge-balancing chloride anion) having the parameters of the Z-matrices fixed 
(i.e., each entity was treated as a rigid body and only optimisation of the relative orientation and 
crystallographic position inside the unit cell were allowed).  The water molecules of crystallisation, 
whose content was unequivocally determined from elemental composition and thermoanalytical studies 
(see Experimental Section and the following paragraphs for discussion of the results), were not included 
in the Monte Carlo optimisation for simplicity.  Due to the use of antibump restraints to facilitate the 
optimisation process and to lead more rapidly to chemically-feasible models, the terminal methyl groups 
of TRIMEB were manually removed from the FHZ matrix imported into FOX.  It is important to 
emphasise that this strategy is chemically- and computationally-feasible since it reduces steric hindrance 
between neighbouring molecules and also minimises (but not removes) the occurrence of overlapping 
atoms which, in the real crystal structure, do not exist due to the conformational flexibility of TRIMEB.   
After full Monte Carlo convergence, the systematic permutation in P21 of the three chemical 
entities led to a structural model whose simulated powder X-ray diffraction pattern compares relatively 
well with the experimental one (calculated weighted residual of Rwp = 0.087) (Figure 1).  Fractional 
atomic coordinates and a CIF file for the hypothetical structural model are supplied as Electronic 
Supporting Information.  These structural studies clearly demonstrate that the cationic 
[Ru([9]aneS3)(bpy)Cl]+ guest complex is not fully included inside the cavity of the TRIMEB host (Figure 
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2), most likely due to its relatively large size.  The cations are instead regularly distributed in-between the 
TRIMEB hosts, occupying the intermolecular void spaces (Figure 2) and in relatively close proximity 
with the charge-balancing Cl- anion.  This structural feature, despite unusual, is not unprecedented for 
cyclodextrin inclusion compounds and was for example reported by K. Harata for the DIMEB complexes 
with p-iodophenol and p-nitrophenol [37].  Nevertheless, it is of considerable importance to stress that the 
packing features of TRIMEB are still typical with the formation of tilted channels in the hypothetical 
structural model running parallel to the c-axis of the unit cell (Figure 3).  The larger tilting angle can be 
associated with the presence of the bulky ruthenium(II) complexes. 
  
 
ACCEPTED MANUSCRIPT 
 
 11 
 
Figure 2 – (Bottom) Experimental data (red circles) and simulated using FOX (lower solid 
blue line) powder X-ray diffraction patterns for [Ru([9]aneS3)(bpy)Cl]Cl·TRIMEB (3).  
(Top) Chemical moieties composing the asymmetric unit of the hypothetical structural model 
of compound 3.  The TRIMEB molecule was simplified for clarity purposes by a ring-shaped 
object solely composed by the seven 	-D-glucopyranoside units. 
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Figure 3 – Crystal packing of [Ru([9]aneS3)(bpy)Cl]Cl·TRIMEB (3) viewed in perspective along the (a) [001], (b) [100] and (c) [010] directions 
of the unit cell, emphasising the tilted channel-type distribution of the cyclodextrin units.  TRIMEB molecules have been simplified for clarity by 
ring-shaped objects composed by the seven 	-D-glucopyranoside units.  [Ru([9]aneS3)(bpy)Cl]+ cations and Cl- anions are drawn in mixed 
polyhedral and ball-and-stick modes. 
  
 
ACCEPTED MANUSCRIPT 
 
 13 
 
 
Thermogravimetric analysis was also useful for the recognition of inclusion complex formation in 
compounds 2 and 3 (Figure 3). The adduct [Ru([9]aneS3)(bpy)Cl]Cl·-CD (2) exhibits a step from room 
temperature up to about 78 °C, assigned to the removal of water molecules located in the -CD cavities 
and in the interstices in-between the macrocycles. The corresponding total weight loss is of ca. 8.6%, 
which indicates that the approximate number of water molecules per -CD molecule is about 9. For 
comparison, plain -CD hydrate shows a similar well-defined step from room temperature up to about 80 
°C, with a mass loss of 14.6% (11 water molecules per -CD molecule). The partial occupation of the -
CD cavities by the guests is usually accompanied by a reduction of hydration waters, thus supporting the 
assumption (from powder XRD data) that a new supramolecular structure was formed between -CD and 
the guest [Ru([9]aneS3)(bpy)Cl]Cl, involving a partial inclusion of the molecule. After the dehydration 
step, the TG curve for 2 features an early decomposition of the host (plain -CD hydrate starts to 
decompose around 270 ºC). This difference is attributed to the promoting effects of the ruthenium 
complex on the decomposition of -cyclodextrin, and is an evidence of a significant strong host-guest 
affinity [38]. 
[Ru([9]aneS3)(bpy)Cl]Cl·TRIMEB (3) has an inverse behaviour. While pure TRIMEB starts to melt 
and decompose at about 175 ºC, compound 3 starts to decompose around 265 ºC. To further investigate 
this unusual feature we have prepared the 1:1 physical mixture of the two components by mechanical 
grinding (inset in Figure 3). Surprisingly, both the adduct and the physical mixture feature similar 
decomposition profiles. We also note that the residual masses at 550 ºC are similar and of about 7%, thus 
further supporting the 1:1 host-to-guest stoichiometry in the inclusion compound 3 as determined by 
microanalysis. The higher thermal stability of both [Ru([9]aneS3)(bpy)Cl]Cl·TRIMEB (3) and its 
corresponding mix are an unusual feature, only observed when TRIMEB (rather than native -CD) is 
used as host, and seems to occur with very specific guest types. We have previously registered this 
thermal decomposition profile for TRIMEB encapsulated metallocenes – Cp2MoCl2 [9] and Cp2NbCl2 [8] 
– and are currently obtaining similar results for other supramolecular TRIMEB adducts [39]. 
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Figure 4 – Thermal decomposition profiles for [Ru([9]aneS3)(bpy)Cl]Cl (1) (- - -), β-CD (·· 
– ·· –), [Ru([9]aneS3)(bpy)Cl]Cl·-CD (2) (- - – - - –), TRIMEB (– - – -) and 
[Ru([9]aneS3)(bpy)Cl]Cl·TRIMEB (3) (– – –). The inset shows a comparison of the TG 
profile for compound 3 (solid, purple) with that of its corresponding physical 1:1 molar 
mixture (pink, dashed). 
 
The 13C{1H} CP/MAS NMR spectra of the complex 1, the hosts -CD and TRIMEB and their 
corresponding inclusion compounds 2 and 3 are shown in Figure 4. Plain -CD hydrate exhibits a 
complex 13C{1H} CP/MAS NMR spectrum with multiple sharp resonances for each type of carbon atom. 
These features have been correlated with different torsion angles about the 	(1
4) linkages [40,41], and 
with torsion angles describing the orientation of the hydroxyl groups [42]. Upon inclusion to give 
[Ru([9]aneS3)(bpy)Cl]Cl·-CD (2) the resonances due to the C1, and C2,3,5 host carbon atoms appear as 
single broad peaks with maxima peaking at  102.3 and 72.8 ppm, respectively, with little or no structure. 
Moreover, resonances associated with carbon atoms C4 and C6 feature a reduction in multiplicity and 
structure. These observations may have been associated with symmetrisation of the -CD macrocycle in 
order to better accommodate the guest molecules [8,10,12-15]. 
The complex 1 features multiple resonances for the thioether [9]aneS3 ring grouped in two sets of 
triplets (from 42 to 25 ppm); this is in agreement with two possible different conformations for this ring, 
as postulated by solution studies by 1H and 13C NMR [19]. These authors proposed that the two possible 
conformations have Cs symmetry, with a plane of symmetry that runs through the Ru, the Cl, one sulfur 
atom and bisects the angle N—Ru—N of the bipyridine ligand. The guest carbon atom resonances are 
also observed in the spectrum of compound 2, though featuring a dramatic loss of multiplicity. This way, 
resonances for the [9]aneS3 carbons are reduced to two broad signals by -CD inclusion and those of 
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bipyridine also feature line broadening, with only one broad signal for carbons a and e. This overall 
pattern may reflect a more symmetric environment around the guest as a result of its incorporation into 
the crystalline lattice of the inclusion compound. 
 
Figure 5 – Solid-state 13C{1H} CP/MAS NMR spectra of (a) [Ru([9]aneS3])(bpy)Cl]Cl (1), 
(b) pure -CD hydrate, (c) the inclusion compound [Ru([9]aneS3])(bpy)Cl]Cl·-CD (2), (d) 
TRIMEB and (e) the inclusion compound [Ru([9]aneS3])(bpy)Cl]Cl·TRIMEB (3). 9S3 
represents the ligand [9]aneS3 and spinning sidebands are denoted by asterisks. For the 
carbon labelling scheme of the cyclodextrins, of the guest ligand bipyridine and the complete 
listing of resonances, please refer to the experimental section. 
 
Like plain β-CD hydrate, the 13C{1H} CP/MAS NMR spectrum of TRIMEB also shows multiple 
resonances for each type of carbon atom. This may be due to a collapsed conformation in the solid state 
by inversion of the conformation of one glucose unit to the 1C4 conformation as observed for TRIMEB 
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monohydrate (form 1), or to an overall asymmetry in the local environment of the glucose units due to 
self inclusion of two primary methoxy groups from a neighbouring molecule, as found for the crystals of 
anhydrate TRIMEB (form 3) [43]. (Note that an unambiguous assignment of the herein used TRIMEB to 
the monohydrate or anhydrate forms from diffraction data could not be made due to the absence of 
reference data collected at room temperature.) The multiplicity is lost for the inclusion compound 
[Ru([9]aneS3])(bpy)Cl]Cl·TRIMEB (3) and only broad peaks are observed, indicating a change in the 
conformation of the host macrocycle [20,21]. Note that at least two resonances are discernible for the 
methyl carbon atoms, indicating that these groups exist in different environments, as a result of the high 
flexibility of their bonds. Such kind of disorder of the primary methoxyl groups is quite common in the 
crystal lattices of TRIMEB inclusion compounds. The resonances for the guest molecule in 3 feature even 
further reduction in multiplicity than for the adduct 2. In fact, only three broad resonances are found for 
the carbons of the [9]aneS3 macrocycle and those of the bipyridine ligand have coalesced into four broad 
signals centred at  155.3, 140.2, 138.2 and 128.6 ppm. 
The FT-IR spectrum of 1 shows the typical bipyridine bands with maxima peaking atν 1642, 1622, 
1599 cm-1.  These appear as shoulders around 1604 and 1600 cm-1 upon inclusion in -CD and TRIMEB, 
respectively (other bands are overlapped by the broad band associated with the deformation vibrational 
mode of the hydration water molecules, centred at 1636 and 1623 cm-1, respectively).  Another band 
assigned to bpy, found at 1470 for the guest 1, shifts to 1465 cm-1 upon -CD and TRIMEB 
encapsulation, whilst the remaining bpy bands remain mostly unshifted. These features are coherent with 
the partial inclusion of the bipyridine fragment proposed by us for adducts 2 and 3. 
In view of better understanding the behaviour of 1 in physiological media, in particular the Ru–Cl 
hydrolysis process and how it is affected by CD encapsulation, a Raman study was carried out for the 
solid samples 1-3 and their solutions, both in water and in physiological serum. The substitution of the 
chloride by a water molecule in the first coordination sphere of Ru(II) is an essential step in the activation 
of the drug in vivo, as the labile H2O will subsequently leave the metal coordination environment enabling 
a covalent bond to be formed between the ion and DNA (possibly with one of the purine or pyrimidine 
bases), besides the probable intercalation of the bipyridine moiety. 
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Figure 6 – Raman spectra of (a) solid [Ru([9]aneS3])(bpy)Cl]Cl (1), (b) solid 
[Ru([9]aneS3])(bpy)Cl]Cl·-CD (2), (c) solid [Ru([9]aneS3])(bpy)Cl]Cl·TRIMEB (3) and (d) 
a 10mM aqueous solution of 1.  
 
 
The Raman spectra for solid [Ru([9]aneS3])(bpy)Cl]Cl (1) at low wavenumber shows several bands 
associated with bpy and (Ru–N) modes (see Table 1 and Figures S3 and S4 in the Supplementary 
Material). These are practically unaffected by inclusion and are also quite stable in solution as they hardly 
suffer modifications by dissolving the samples 1-3 in water or serum. An exception is found for the band 
at 477 cm-1 (Figure 6), that reveals a shoulder in adducts 2 and 3 (see Table 1). In addition, the bands at 
477 and 495 cm-1 feature a slight increase in intensity in the spectrum of solid 2 (but not in that of solid 
3).  
Interestingly, the (Ru–Cl) stretching modes at 282 and 298 cm-1 for 1 are also affected by 
encapsulation in both hosts, appearing as broad bands centred around 294 for 2 and 288 cm-1 for 3; this 
may reflect the more symmetric environment around the guest in the supramolecular adducts. Upon 
dissolution of compounds 1-3 the (Ru–Cl) weak bands disappear, either when using water or serum. 
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Table 1 – Selected vibrational modes for compounds 1-3. 
Selected bands (cm-1)  
1 2 3 serum 8mM 
solution of 1 
Approximate description 
282, 298 294 288 298 (Ru–Cl) * 
326, 338 (sh) 326, 340 (sh) 326, 340 326, 338 (Ru–N) 
371 371 372 — (Ru–N) and (C–C) : bpy ** 
477 477, 482 477, 482 — Ru–bipyridine *** 
(*) By reference to the Mo–Cl mode reported for molybdenocene at 263 cm-1 [9]. 
(**) As calculated by Túlio E. Chavez-Gil et al. [44]. 
(***) By reference to a vibrational mode reported for [Ru(bpy)3]2+ by H. Riesen et al. [45]. 
 
 
These vibrational spectroscopic results suggest that in solution the interaction between the CD hosts 
and 1 remain somehow identical to that proposed in the solid state.  The disappearance of the (Ru–Cl) 
bands is indicative of a complete hydrolysis of the chloride, even when [Ru([9]aneS3])(bpy)Cl]Cl is 
encapsulated in -CD and TRIMEB (see Figures S3 and S4), which occurs promptly both in aqueous and 
in physiological media ([Cl-] = 0.9% (w/v)= 154 mmol.dm-3).  
 
4. Concluding Remarks 
 
Inclusion compounds comprising cyclodextrins and the ruthenium(II) complex with the face 
capping ligand trithiacyclononane and with 2,2’-bipyridine have been prepared with a 1:1 host-to-guest 
stoichiometry, and characterised in the solid state by various techniques, including powder diffraction 
studies (XRD). 
The low crystallinity of [Ru([9]aneS3])(bpy)Cl]Cl·-CD (2) prevented a complete structural 
description based on powder XRD. Nevertheless, the compound could be indexed with a typical 
monoclinic (P21) unit cell having dimensions slightly larger than those found for pure -CD and similar 
to that of [CuCl2(H2O)2]·-CD [29]. Thus, it is proposed a partial inclusion of [Ru([9]aneS3])(bpy)Cl]Cl 
with its bulky part protruding from the CD cavity. 
Monte Carlo structural optimisation using powder X-ray data of 
[Ru([9]aneS3])(bpy)Cl]Cl·TRIMEB (3) allowed the calculation of a hypothetical structural model in 
which the cationic [Ru([9]aneS3])(bpy)Cl]+ guest complex is located mostly outside the TRIMEB cavity 
host (as also proposed for compound 2), most likely due to its relatively large size. The orientation of 
TRIMEB molecules is typical, forming tilted channels running parallel to the c-axis of the unit cell. 
FT-IR data further validate the proposed supramolecular interactions between the CDs and 1 as it 
points to partial inclusion of the bpy fragment in adducts 2 and 3. TG shows good host-to-guest affinity in 
both compounds and 13C{1H} CP/MAS NMR depicts symmetrisation of the hosts and the guest carbon 
resonances as a result of their mutual interaction. 
Raman studies on the hydrolysis of the Ru–Cl bond show that the two cyclodextrins are unable to 
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protect it: dissolution of either the complex [Ru([9]aneS3])(bpy)Cl]Cl (1) or the adducts 2 and 3 resulted 
in loss of the chlorine ligand. Improvement of the chemical design for these compounds is thus needed in 
order to avoid hydrolysis to take place before they reach its biological target, and thus hinder competition 
by other biomolecules (e.g. glutathione or albumin). 
Furthermore, investigation about the effect of CD encapsulation on the cytotoxic activity of 
ruthenium(II) compounds with planar amines will be carried out. Molecular encapsulation of this class of 
complexes may be advantageous in several ways from a pharmaceutical point of view, such as enhancing 
the solubility of complexes in water, avoiding in vivo inactivation and reducing the cytotoxic effects 
towards healthy cells. 
 
Electronic Supporting Information 
Le Bail whole-powder-diffraction-pattern profile fittings in the monoclinic P21 space group for 
compounds [Ru([9]aneS3])(bpy)Cl]Cl·-CD (2) and [Ru([9]aneS3])(bpy)Cl]Cl·TRIMEB (3).  Table with 
the fractional atomic coordinates (as supplied by FOX) and CIF file with the optimised structural model 
of [Ru([9]aneS3])(bpy)Cl]Cl·TRIMEB. Raman spectra of serum 8mM solutions of 
[Ru([9]aneS3])(bpy)Cl]Cl (1) and 2 compared with the spectrum of solid 2, and of serum solutions of 1 
(8mM) and 3 (10mM) compared with the spectrum of solid 3.  
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Graphical abstract 
 
 
[Ru([9]aneS3)(bpy)Cl]Cl was immobilised in -CD and TRIMEB yielding two crystalline 1:1 adducts 
studied by powder XRD, TGA, 13C{1H} CP/MAS NMR, FT-IR and Raman. For 
[Ru([9]aneS3)(bpy)Cl]Cl·TRIMEB a channel packing mode is proposed, obtained by Monte Carlo 
optimisation of the XRD data.  
 
 
